Oxford Sciences Innovation has returned to back a $30m funding round for Genomics, having previously contributed to a 2018 series B round.

Genomics, a UK-based precision healthcare spinout of University of Oxford, closed a $30m funding round yesterday backed by university venture fund Oxford Sciences Innovation (OSI). Foresite Capital and F-Prime Capital, an investment affiliate of financial services group Fidelity, and Lansdowne Partners also participated in the round. Founded in 2014, Genomics has developed a machine learning-powered…

The rest of this content is only accessible to University Venturing: News, Data and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.